RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Leung TinChung to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Back to Details
This is a "connection" page, showing publications Leung TinChung has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Leung TinChung
Connection Strength
0.350
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  1. Somasagara RR, Huang X, Xu C, Haider J, Serody JS, Armistead PM, Leung T. Targeted therapy of human leukemia xenografts in immunodeficient zebrafish. Sci Rep. 2021 03 11; 11(1):5715.
    View in: PubMed
    Score: 0.350
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support